CRISPR Therapeutics AG
CRSP
$44.52
-$1.01-2.22%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
1/23/2025
-
MarketBeat
3/8/2025
-
MarketBeat
3/7/2025
-
MarketBeat
3/6/2025
-
MarketBeat
3/6/2025
-
Stock Options Channel
3/6/2025
-
MarketBeat
3/6/2025
-
MarketBeat
3/5/2025
-
MarketBeat
3/4/2025
-
MarketBeat
3/4/2025
-
Tickeron - Stocks
3/3/2025
-
MarketBeat
3/3/2025
-
Seeking Alpha: Transcripts
3/3/2025
-
SeekingAlpha
3/3/2025
-
Market News Video
3/3/2025
-
Zacks Investment Research
3/2/2025
-
MarketBeat
3/1/2025
-
MarketBeat
3/1/2025
-
MarketBeat
3/1/2025
-
Ticker Report
3/1/2025
-
GuruFocus
3/1/2025
-
Fool.com Headlines
2/28/2025
-
Tickeron - Stocks
2/27/2025
-
MarketBeat
2/27/2025
-
Simply Wall St
1/7/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 11, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
41 41 561 32 77
Address
Baarerstrasse 14
Zug, 6300
Zug, 6300
Country
Year Founded
Business Description
Sector
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats...
more
